RC
Therapeutic Areas
Centrient Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Portfolio Diversification | Broadening API/FDF offerings in antibiotics, statins, anti-fungals | Commercial Development |
| Biotechnology Capability Development | Transition to fermentation/biocatalysis processes | Development |
| Sustainable Manufacturing Initiatives | Projects for renewable energy, waste reduction, water conservation | Implementation |
| Supply Chain Resilience & Localization | Securing and localizing production, especially for antibiotics in Europe | Strategic Development |